Quantum量子訊息有限公司
← 最新全球產業報告

Natural Biomaterials Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-05-07 · 136 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 86.7 Bn
2033 年預估規模
USD 103.3 Bn
年複合成長率 CAGR
4.8%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Chemicals & Materials出版日期 2026-05-07頁數 136報告編號 CMI2535

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Natural Biomaterials Market, By Product Type (Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin/chitosan, Others), By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Neurological Disorders/Central Nervous Systems, Tissue Engineering, Ophthalmology, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa)

報告摘要

Biomaterials are regarded as non-drug material, which is used for enhancing or replacing and treating any tissue, organ or function in an organism. The definition of biomaterial was reframed as a non-drug substance, which is suitable for inclusions in systems, replacing or augmenting the function of body tissue or organ. This materials can be synthetic or natural, non-living or living, and are made of multiple components that interact with biological system. They are compatible to be used in place of living tissues in organisms. Market Dynamics Increase in investment in research and development of precision medicine and molecular biology is the key factor augmenting the market. Rise in geriatric population that is prone to various chronic diseases is another factor boosting the demand for natural biomaterials. Growth in usage of biomaterial science in various advanced medical technologies, such as drug delivery devices, plastic surgery, tissue engineering, and other medical implants, is expected to propel the market growth in the near future. Biomaterials are widely used in drug delivery and are biodegradable so that they can disappear from organism after the completion of their function. These can be used in medical applications as replacement to bones, cartilage regeneration during an orthopedic surgery, collagen membrane and regenerative dentistry. Advancements in tissue designing and increase in number of knee and hip replacement surgeries have created lucrative opportunities for the global natural biomaterials market growth. Extensive research and development activities supported by key players to develop advanced biomaterial products is also anticipated to boost the market growth. Key features of the study • This report provides in-depth analysis of global natural biomaterials market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year. • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global natural biomaterials market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans • Key companies covered as a part of this study include, BASF SE, Biomet, Inc., Invibio Ltd., Mimetis Biomaterials, Royal DSM, Corbion N.V., Botiss Biomaterials GmbH, and Medtronic, Inc. • Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future products launches, technology up gradation, market expansion, and marketing tactics • The global natural biomaterials market report caters to various stakeholders in this industry including investors, suppliers, natural biomaterials manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global natural biomaterials market Market Segmentation • By Product Type (Revenue, USD Bn, 2021-2033) o Hyaluronic Acid o Collagen o Gelatin o Fibrin o Cellulose o Chitin/chitosan o Others • By Application (Revenue, USD Bn, 2021-2033) o Cardiovascular o Orthopedic o Dental o Plastic Surgery o Wound Healing o Neurology o Neurological Disorders/Central Nervous Systems o Tissue Engineering o Ophthalmology o Others • By Region (Revenue, USD Bn, 2021-2033) o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players o BASF SE o Biomet, Inc. o Invibio Ltd. o Mimetis Biomaterials o Royal DSM o Corbion N.V. o Botiss Biomaterials GmbH o Medtronic, Inc.
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Product Type  Market Snippet, By Application  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  PEST Analysis  PORTER’s Five Forces Analysis  Market Opportunities  Regulatory Scenario  Key Developments  Industry Trend 4. Global Natural Biomaterials Market, By Product Type, 2021-2033 (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hyaluronic Acid  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Collagen  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Gelatin  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Fibrin  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Cellulose  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Chitin/Chitosan  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Natural Biomaterials Market, By Application, 2021-2033 (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022-2033  Segment Trends o Cardiovascular  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Orthopedic  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Dental  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Plastic Surgery  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Wound Healing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Neurology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Neurological Disorders/Central Nervous Systems  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Tissue Engineering  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Ophthalmology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Natural Biomaterials Market, By Region, 2021-2033 (USD Bn) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Region, 2021-2033 o North America  Market Share Analysis, By Country, 2021-2033  Y-o-Y Growth Analysis, By Country, 2021-2033  Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)  Market Size and Forecast, By Application, 2021-2033 (USD Bn)  Countries o U.S. o Canada o Latin America  Market Share Analysis, By Country, 2021-2033  Y-o-Y Growth Analysis, By Country, 2021-2033  Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)  Market Size and Forecast, By Application, 2021-2033 (USD Bn)  Countries o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Market Share Analysis, By Country, 2021-2033  Y-o-Y Growth Analysis, By Country, 2021-2033  Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)  Market Size and Forecast, By Application, 2021-2033 (USD Bn)  Countries o France o Germany o Italy o Spain o U.K. o Russia o Rest of Europe o Asia Pacific  Market Share Analysis, By Country, 2021-2033  Y-o-Y Growth Analysis, By Country, 2021-2033  Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)  Market Size and Forecast, By Application, 2021-2033 (USD Bn)  Countries o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East & Africa  Market Share Analysis, By Country, 2021-2033  Y-o-Y Growth Analysis, By Country, 2021-2033  Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)  Market Size and Forecast, By Application, 2021-2033 (USD Bn)  Countries o Middle East o Africa 7. Competitive Landscape o Heat Map Analysis o Market Share Analysis (3x3 Matrix) o Company Profiles  BASF SE o Company Overview o Product Portfolio o Recent Developments/Updates  Biomet, Inc. o Company Overview o Product Portfolio o Recent Developments/Updates  Invibio Ltd. o Company Overview o Product Portfolio o Recent Developments/Updates  Botiss Biomaterials GmbH o Company Overview o Product Portfolio o Recent Developments/Updates  Medtronic, Inc. o Company Overview o Product Portfolio o Recent Developments/Updates  Mimetis Biomaterials o Company Overview o Product Portfolio o Recent Developments/Updates  Royal DSM o Company Overview o Product Portfolio o Recent Developments/Updates  Corbion N.V. o Company Overview o Product Portfolio o Recent Developments/Updates 8. Section o References o Research Methodology o About Us and Sales Contact

提及公司

BASF SEBiomet, Inc.Invibio Ltd.Mimetis BiomaterialsRoyal DSMCorbion N.V.Botiss Biomaterials GmbHMedtronic, Inc.

同分類最新報告(化學與材料)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們